PRE 14A

PRE 14A Filing

Company: Oncotelic Therapeutics, Inc.
Filed: April 13, 2020
Period of Report: April 13, 2020
Accession Number: 0001493152-20-006239

View Document ↗ View on SEC.gov ↗